本页面由Tiger Trade Technology Pte. Ltd.提供服务

Evoke Pharma Inc.

11.00
0.0000
成交量:- -
成交额:51.76万
市值:1,894.64万
市盈率:-5.42
高:11.00
开:11.00
低:11.00
收:11.00
52周最高:11.00
52周最低:1.94
股本:172.24万
流通股本:87.17万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.0307
每股收益(LYR):-2.8094
净资产收益率:-134.88%
总资产收益率:-21.78%
市净率:5.64
市盈率(LYR):-3.92

数据加载中...

2025/12/17

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/17

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/17

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/17

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/17

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/17

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2025/12/17

重要事件披露

Form 8-K - Current report
2025/11/13

重要事件披露

Form 8-K - Current report
2025/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

重要事件披露

Form 8-K - Current report
2025/08/14

重要事件披露

Form 8-K - Current report
2025/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/07/09

重要事件披露

Form 8-K - Current report
2025/05/22

重要事件披露

Form 8-K - Current report
2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/14

重要事件披露

Form 8-K - Current report
2025/03/14

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/13

重要事件披露

Form 8-K - Current report